Clinical Trials Directory

Trials / Terminated

TerminatedNCT00920569

Recirculation, Oxygenator Blood Volume and Cardiac Output Measurements During Extracorporeal Membrane Oxygenation

Measurement of Recirculation, Oxygenator Blood Volume and Cardiac Output in ECMO Using a Modified Transonic Systems (tm) HD02 Monitoring System

Status
Terminated
Phase
Study type
Observational
Enrollment
8 (actual)
Sponsor
Transonic Systems Inc. · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study is to test the usefulness of ultrasound dilution measurements in patients on extracorporeal membrane oxygenation. Measurements may include; efficiency of support (recirculation), amount of clotting in the oxygenator (oxygenator blood volume), and how well the heart is working (cardiac output). At the present time there are no devices available to perform these functions.

Detailed description

At the present time there are no devices available to measure recirculation, oxygenator blood volume and cardiac output in patients on extracorporeal membrane oxygenation. The study uses an external monitor, laptop computer, clamp on flowsensors and ultrasound dilution technology to measure blood flow. Measurements are made by injecting 0.5 - 1 ml/kg of sterile isotonic saline into the patient's extracorporeal circuit. The subject will be monitored throughout the measurements. The measurements will be coordinated with the regular care of the extracorporeal circuit.

Conditions

Timeline

Start date
2006-05-01
Primary completion
2008-08-01
Completion
2008-08-01
First posted
2009-06-15
Last updated
2016-05-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00920569. Inclusion in this directory is not an endorsement.